Skip to content
HOME Insights

See How Ncardia Is Supporting the Shift From Animal Models With iPSC Technology

Ncardia author image

By Ncardia

Ncardia post featured image

Video

Live animal models, especially non-human primates (NHPs), come with growing ethical, regulatory and reproducibility challenges. In this video, Mariana Argenziano, Ph.D., associate director of manufacturing technology at Ncardia, shares how iPSC technology is helping researchers move toward more ethical, scalable and human-relevant drug development. 

Watch it now to hear how Ncardia’s platform:

  • Addresses FDA guidance on reducing animal use
  • Provides ready-to-use, high-fidelity cardiomyocytes   
  • Offers cost-effective and reproducible alternatives to in vivo NHP models in preclinical safety testing  
  • Enables translation across species with NHP- and human-derived cells  

 

If you’re looking to build a more ethical, efficient and predictive preclinical pipeline, this is the place to start.  

 
Topics